News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kronenfeld Mark A.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Kronenfeld Mark A. (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 1,775 shares
@ $0
Granted 12,925 options to buy
@ $38.74, valued at
$500.7k
|
|
| 06/12/2023 |
4
| Kronenfeld Mark A. (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 15,000 shares
@ $37.04, valued at
$555.6k
Exercised 15,000 options to buy
@ $29.9, valued at
$448.5k
|
|
| 06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
4
| Kronenfeld Mark A. (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 1,260 shares
@ $0
Granted 8,027 options to buy
@ $47.65, valued at
$382.5k
|
|
| 06/06/2019 |
4
| Kronenfeld Mark A. (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 4,134 shares
@ $0
Granted 8,437 options to buy
@ $43.54, valued at
$367.3k
|
|
| 03/08/2019 |
4
| Kronenfeld Mark A. (Director) has filed a Form 4 on Pacira Pharmaceuticals, Inc.|
Txns:
| Bought 700 shares
@ $38.72, valued at
$27.1k
Bought 1,000 shares
@ $39.14, valued at
$39.1k
|
|
| 08/30/2018 |
4
| Kronenfeld Mark A. (Director) has filed a Form 4 on Pacira Pharmaceuticals, Inc.|
Txns:
| Bought 1,000 shares
@ $44.6112, valued at
$44.6k
|
|
| 06/15/2018 |
4
| Kronenfeld Mark A. (Director) has filed a Form 4 on Pacira Pharmaceuticals, Inc.|
Txns:
| Granted 782 shares
@ $0
Granted 4,693 options to buy
@ $38.35, valued at
$180k
|
|
| 11/13/2017 |
4
| Kronenfeld Mark A. (Director) has filed a Form 4 on Pacira Pharmaceuticals, Inc.|
Txns:
| Bought 1,000 shares
@ $41.6025, valued at
$41.6k
|
|
| 06/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/17/2016 |
4
| Kronenfeld Mark A. (Director) has filed a Form 4 on Pacira Pharmaceuticals, Inc.|
Txns:
| Granted 1,488 shares
@ $0
Granted 2,975 options to buy
@ $40.34, valued at
$120k
|
|
| 06/08/2016 |
4
| Kronenfeld Mark A. (Director) has filed a Form 4 on Pacira Pharmaceuticals, Inc.|
Txns:
| Sold 900 shares
@ $46.95, valued at
$42.3k
|
|
|
|